| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (OTCEM:CARM) through any online brokerage.
There are no as such competitors for CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc..
CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. has a consensus price target of $0.90.
The stock price for CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (OTCEM: CARM) is $0.0002 last updated October 21, 2026 at 3:07 PM EDT.
There are no upcoming dividends for CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc..
CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc..
CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.
